Gut podcast
Summary: From June 2023, all our podcasts will move to https://gutbmj.podbean.com. You can continue with your subscription on your favourite podcast App. Gut is a leading international journal in gastroenterology and hepatology. It has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage of all areas in gastroenterology. Regular features include articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries. Subscribers to Gut also receive Frontline Gastroenterology (FG). The Gut Podcast discusses highlights from its issues monthly. Please subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
- Visit Website
- RSS
- Artist: BMJ Group
- Copyright: 643134
Podcasts:
Gut education editor Mairi Mclean talks to Dr Shuji Ogino, from Harvard Medical School, about his paper on the asessment of colorectal cancer molecular features.See also:Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum (http://tinyurl.com/bgs7o7u)
Mairi Mclean (Gut education editor) talks to Maria Rescigno (European Institute of Oncology, Milan) about her editor’s choice paper - Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. (http://tinyurl.com/a8z4uqr)
Mairi Mclean (Gut education editor) talks to Maria Rescigno (European Institute of Oncology, Milan) about her editor’s choice paper - Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. (http://tinyurl.com/a8z4uqr)
Mairi McLean (Gut’s education editor) discusses August’s editor’s choice paper, on NKT-associated hedgehog and osteopontin and their role in non-alcoholic fatty liver disease, with authors Anna Mae Diehl (chief, Division of Gastroenterology, Duke University), Wing-Kin Syn (head of Regeneration and Repair, Institute of Hepatology, London) and Steve Choi (assistant professor, Division of Gastroenterology, Duke University).See also:NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease (http://tinyurl.com/aq5jt9p)
Mairi McLean (Gut’s education editor) discusses August’s editor’s choice paper, on NKT-associated hedgehog and osteopontin and their role in non-alcoholic fatty liver disease, with authors Anna Mae Diehl (chief, Division of Gastroenterology, Duke University), Wing-Kin Syn (head of Regeneration and Repair, Institute of Hepatology, London) and Steve Choi (assistant professor, Division of Gastroenterology, Duke University).See also:NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease (http://tinyurl.com/aq5jt9p)
The Bowel Cancer Screening Programme has now been operating in England for six years, so how effective has it been in terms of take-up and detection? A paper in Gut examines the outcomes, and education editor Mairi McLean talks to some of the authors to hear what they found.See also:Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests (http://tinyurl.com/ax3cnlm)
The Bowel Cancer Screening Programme has now been operating in England for six years, so how effective has it been in terms of take-up and detection? A paper in Gut examines the outcomes, and education editor Mairi McLean talks to some of the authors to hear what they found.See also:Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests (http://tinyurl.com/ax3cnlm)
Recent studies have identified mucosal healing as a key prognostic parameter in the management of inflammatory bowel diseases. In this podcast Mairi McLean, education editor for Gut, talks to Marcus Neurath from the University of Erlangen-Nuremberg, and Simon Travis from John Radcliffe Hospital in Oxford, about their systematic review of the clinical studies on mucosal healing. They discuss the effects of anti-inflammatory or immunosuppressive drugs, and the implications of mucosal healing for subsequent clinical management in patients with IBD.See also:Mucosal healing in inflammatory bowel diseases: a systematic review (http://tinyurl.com/bk7tglj)
Recent studies have identified mucosal healing as a key prognostic parameter in the management of inflammatory bowel diseases. In this podcast Mairi McLean, education editor for Gut, talks to Marcus Neurath from the University of Erlangen-Nuremberg, and Simon Travis from John Radcliffe Hospital in Oxford, about their systematic review of the clinical studies on mucosal healing. They discuss the effects of anti-inflammatory or immunosuppressive drugs, and the implications of mucosal healing for subsequent clinical management in patients with IBD.See also:Mucosal healing in inflammatory bowel diseases: a systematic review (http://tinyurl.com/bk7tglj)
Gut’s education editor Mairi McLean talks to Peter Mannon, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, and Walter Reinisch, Department of Medicine IV, Division Gastroenterology and Hepatology, Medical University of Vienna, about their research looking at interluekin 13 and its role in gut defence and inflammation.See also:Interleukin 13 and its role in gut defence and inflammation (http://tinyurl.com/akzwjxo)
Gut’s education editor Mairi McLean talks to Peter Mannon, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, and Walter Reinisch, Department of Medicine IV, Division Gastroenterology and Hepatology, Medical University of Vienna, about their research looking at interluekin 13 and its role in gut defence and inflammation.See also:Interleukin 13 and its role in gut defence and inflammation (http://tinyurl.com/akzwjxo)
Mairi McLean, Gut’s education editor, talks to Peter Banks, Division of Gastroenterology, Hepatology, and Endoscopy, Harvard Medical School, and Michael Sarr, Department of Surgery, Mayo Clinic, Rochester, about their revision of the Atlanta classification of acute pancreatitis.See also:Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus (http://tinyurl.com/arb6fg6)
Mairi McLean, Gut’s education editor, talks to Peter Banks, Division of Gastroenterology, Hepatology, and Endoscopy, Harvard Medical School, and Michael Sarr, Department of Surgery, Mayo Clinic, Rochester, about their revision of the Atlanta classification of acute pancreatitis.See also:Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus (http://tinyurl.com/arb6fg6)
